Compositions and methods for inhibiting g protein signaling
AssigneeUniversity of Rochester
InventorsAlan V. Smrcka, Jose Font, Tabetha Bonacci
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for identifying agents which bind to specific amino acid residues of the protein interaction site of G protein β protein subunit. Compounds identified in accordance with the assay of the invention and methods for using the compound for modulating at least one activity of a G protein are also provide.
Claims7
A method for identifying an agent that modulates at least one activity of a G protein comprising contacting a G protein β subunit with a test agent and determining whether the agent interacts with at least one amino acid residue of the protein interaction site of the β subunit thereby identifying an agent that modulates at least one activity of the G protein.
A method for identifying an agent that binds at least one amino acid residue of the protein interaction site of the β subunit comprising
- contacting a G protein β subunit with a test agent in the presence of a peptide that binds at least one amino acid residue of the protein interaction site of β subunit;
- and
- determining whether the agent inhibits the binding of the peptide to the at least one amino acid residue of the protein interaction site of the β subunit thereby identifying an agent that binds at least one amino acid residue of the protein interaction site of the β subunit.
A kit for identifying an agent that binds at least one amino acid residue of the protein interaction site of the β subunit, said kit comprising a SIGK peptide or SIGK peptide derivative.
A method for modulating at least one activity of a G protein comprising contacting a G protein with an effective amount of an agent that interacts with at least one amino acid residue of the protein interaction site of the G protein β subunit so that at least one activity of the G protein is modulated.
A method for preventing or treating a disease or condition involving at least one G protein βγ subunit activity comprising administering to a patient having or at risk of having a disease or condition involving at least one G protein βγ subunit activity an effective amount of an agent that interacts with at least one amino acid residue of the protein interaction site of the G protein β subunit so that the at least one activity of the G protein is modulated thereby preventing or treating the disease or condition involving the at least one G protein βγsubunit activity.
Dependencies are inferred from the claim text.